Rosemary extract has become one of the more interesting cosmeceutical ingredients in recent formulation work — not because of its traditional reputation, but because the two compounds it yields, carnosic acid and rosmarinic acid, have distinctly different mechanisms that are relevant to different skin and hair applications. This guide covers what the published research actually shows, which compound to specify for which application, and what cosmetic formulators need to know before purchasing bulk ingredient.
Two Compounds, Two Different Skin Applications
The most important thing to understand before specifying rosemary extract for cosmetic use is that carnosic acid and rosmarinic acid are not interchangeable. They have opposite solubility profiles, different mechanisms, and perform best in different phases of a formulation.
| Property | Carnosic Acid | Rosmarinic Acid |
|---|---|---|
| Solubility | Lipid-soluble (oil phase) | Water-soluble (aqueous phase) |
| Primary skin mechanism | Nrf2/HO-1 activation; lipid-phase antioxidant protection | NF-κB inhibition; UVB-induced oxidative damage protection; direct ROS scavenging |
| Hair follicle research | Dermal papilla cell viability; Wnt/β-catenin pathway studied in published preclinical research[1] | Scalp skin antioxidant; indirect support via anti-inflammatory pathway |
| Cosmetic formulation fit | Oil serums, anhydrous balms, hair oils, lipid-phase actives | Aqueous serums, toners, water-phase emulsions, leave-on scalp treatments |
| Skin-brightening activity | Indirect — antioxidant protection against oxidative pigmentation | Tyrosinase inhibitory activity studied in published in vitro research |
| INCI name | Rosmarinus Officinalis (Rosemary) Leaf Extract — same INCI for both; specify compound on technical documentation | |
For a full cross-application comparison — including food preservation, supplement bioavailability, and stability data — see Carnosic Acid vs Rosmarinic Acid: A Formulator’s Guide.
Carnosic Acid in Skin and Hair Formulations
Antioxidant Protection in Oil-Phase Formulations
Carnosic acid’s lipid solubility makes it a natural fit for oil-phase cosmetic applications. It acts as both an antioxidant ingredient and a formulation stabiliser — protecting the oil phase from oxidative rancidity while simultaneously delivering antioxidant activity to the skin’s lipid barrier. This dual function is practically useful: at the concentrations used in cosmetic serums, carnosic acid contributes to both shelf-life stability and skin antioxidant activity.
The underlying mechanism — Nrf2/Keap1 pathway activation — is the same in skin cells as in other tissue types. Under oxidative stress (UV exposure, pollution, metabolic stress), carnosic acid converts to an electrophilic form that triggers upregulation of the skin’s own antioxidant enzymes, including HO-1 and glutathione S-transferase.[4] This on-demand activation means it is selectively active in stressed cells — a relevant property for anti-aging and environmental protection positioning.
Hair Follicle Biology — What the Published Research Shows
The most searched question about carnosic acid in cosmetics is whether it supports hair growth — and there is now published preclinical research directly addressing this. A 2025 review in Planta Medica (Singh et al.) systematically reviewed carnosic acid’s potential in hair follicle biology, documenting several preclinical mechanisms studied in dermal papilla cell models: enhancement of dermal papilla cell viability under oxidative stress conditions, upregulation of Wnt/β-catenin signalling pathway activity (a key pathway in hair follicle cycling), and inhibition of 5α-reductase activity in preclinical models — the same enzyme targeted by finasteride in approved treatments for androgenetic hair thinning.[1]
These are preclinical cell and animal model findings. There are no published human clinical trials confirming efficacy for hair growth at the time of writing. The review authors noted that poor aqueous solubility limits carnosic acid’s delivery to the scalp in conventional formulations, and that nanoparticle-based or emulsion delivery systems are being explored to improve penetration.
Rosmarinic Acid in Skin Formulations
UVB-Induced Oxidative Damage Protection
A 2024 study published in Biomolecules & Therapeutics investigated rosmarinic acid (RA) in human keratinocyte (HaCaT) cells and a hairless mouse skin model under UVB irradiation. RA treatment significantly attenuated UVB-induced cell damage, reduced intracellular ROS levels, and activated the AKT/ERK-Nrf2-GSH antioxidant pathway. The study confirmed cytoprotective effects against UVB-induced oxidative stress at concentrations relevant to cosmetic formulations.[2]
The water solubility of rosmarinic acid makes it directly applicable to aqueous cosmetic formats — toners, essence serums, water-based emulsions, and leave-on scalp treatments — without requiring solubilisation aids. It distributes evenly in the aqueous phase and does not contribute an oil or greasy feel to finished formulations.
Skin-Brightening and Anti-Pigmentation
Rosmarinic acid has documented tyrosinase inhibitory activity in published in vitro research — tyrosinase is the key enzyme in melanin biosynthesis, making its inhibition the target of most natural skin-brightening approaches. Published research has confirmed antioxidant and tyrosinase inhibitory activity of rosmarinic acid with good skin biocompatibility in reconstructed skin models.[3] This positions rosmarinic acid as a botanical ingredient for brightening and anti-pigmentation formulations alongside better-established tyrosinase inhibitors such as kojic acid and niacinamide.
Formulation Guide: Which Grade for Which Application
| Application | Compound | Grade | Formulation Notes |
|---|---|---|---|
| Antioxidant face oil / oil serum | Carnosic acid | 60% HPLC | Dissolve in carrier oil; effective at 0.05–0.2% carnosic acid in finished formula |
| Anti-aging emulsion (oil-phase active) | Carnosic acid | 10% or 60% HPLC | Add to oil phase; combine with tocopherol for enhanced antioxidant synergy |
| Hair oil / scalp treatment (oil-phase) | Carnosic acid | 60% HPLC | Oil-soluble; pairs with rosemary essential oil and castor oil in scalp oils |
| Aqueous brightening serum | Rosmarinic acid | 50% or 98% HPLC | Add to water phase; stable pH 4–7; pairs with niacinamide and vitamin C |
| Toner / essence (aqueous) | Rosmarinic acid | 10% or 50% HPLC | Fully water-soluble; no solubiliser required; light, non-greasy texture |
| Leave-on scalp serum (aqueous) | Rosmarinic acid | 50% HPLC | Apply to aqueous phase; anti-inflammatory and antioxidant activity on scalp skin |
| Multi-active emulsion (both phases) | Both | 10% CA + 50% RA | CA in oil phase, RA in water phase — full-spectrum antioxidant coverage in one formula |
Stability Considerations for Cosmetic Formulators
Both compounds are sensitive to heat and light — standard precautions apply. A few cosmetic-specific points worth noting:
- Carnosic acid above 180°C converts to carnosol — carnosol is also an antioxidant, but the conversion means high-temperature processing (hot-fill emulsions above this threshold) will change the active profile. Add carnosic acid in the cool-down phase below 40°C
- Carnosic acid in alkaline formulas degrades faster — pH above 8 accelerates degradation. Most cosmetic formulas are pH 4.5–7, so this is rarely an issue in practice, but check your finished formula pH if using in a soap or alkaline system
- Rosmarinic acid is more pH-stable across the typical cosmetic range (pH 3–8), making it the lower-maintenance option for formulators working across multiple product types
- Both benefit from antioxidant pairing — vitamin E (tocopherol) pairs well with carnosic acid in oil-phase formulas; vitamin C (ascorbic acid) can complement rosmarinic acid in aqueous formulas as a co-antioxidant
Regulatory Notes for Cosmetic Applications
Both compounds share the same INCI name: Rosmarinus Officinalis (Rosemary) Leaf Extract. In EU cosmetic products, this ingredient is listed in the Cosing database as a permitted cosmetic ingredient. No specific concentration restrictions apply, but a safety assessment under EU Cosmetics Regulation 1223/2009 is required for each formulation and concentration before market placement.[5]
For claim substantiation: antioxidant claims are the most straightforwardly supported by the published evidence base. Hair growth or hair loss claims require careful wording — staying within cosmetic claim boundaries (“helps maintain scalp antioxidant environment”) rather than drug-claim territory (“treats hair loss”) is essential. In vitro and preclinical data can support the claim narrative but should not be presented as clinical proof of efficacy.
For bulk carnosic acid (10%, 60%) and rosmarinic acid (10%, 50%, 98%) standardised to HPLC with full third-party COA per batch, see Valeherb’s rosemary extract product page. For how these two compounds compare in food and supplement applications, see Carnosic Acid vs Rosmarinic Acid: A Formulator’s Guide.
Frequently Asked Questions
Does carnosic acid help with hair growth?
Published preclinical research — primarily cell studies using dermal papilla cells — has documented several relevant mechanisms: improved dermal papilla cell viability under oxidative stress, upregulation of Wnt/β-catenin signalling, and 5α-reductase inhibitory activity. A 2025 review in Planta Medica systematically reviewed this preclinical evidence. However, there are no published human clinical trials on carnosic acid for hair growth at the time of writing. Cosmetic claims should reflect this: antioxidant scalp support and preclinical mechanistic evidence are appropriate; clinical hair loss treatment claims are not supported by the current data and cross into drug claim territory in most markets.
Which is better for skin — carnosic acid or rosmarinic acid?
It depends on your formulation and what you are trying to achieve. Carnosic acid is better for oil-phase formulas — face oils, anhydrous serums, emulsion oil phases — where its lipid solubility is an asset. It is also better for hair oils and oil-based scalp treatments. Rosmarinic acid is better for aqueous-phase formulas — toners, water-based serums, leave-on scalp treatments — where its water solubility allows even distribution without solubilisers. For skin brightening, rosmarinic acid has more direct published tyrosinase inhibitory evidence. For anti-aging in an oil-phase formula, carnosic acid’s Nrf2 activation mechanism is more relevant.
What is the recommended use level for rosemary extract in cosmetics?
There is no mandated maximum for cosmetic use (unlike the E392 food application), but practical guidance from published formulation research suggests: carnosic acid at 0.05–0.3% in finished formula (expressed as carnosic acid content, not extract weight) for antioxidant activity without sensory impact; rosmarinic acid at 0.1–1% in finished formula. At higher levels, carnosic acid can impart a faint herbal note — using the 60% HPLC grade allows effective inclusion at lower extract weight, keeping sensory impact below threshold. Safety assessment under EU Regulation 1223/2009 should confirm the specific concentration used in each formulation.
References
[1] Singh P, Hazarika A, Mukherjee PK, et al. (2025). Therapeutic potential of carnosic acid in alopecia: a mechanistic perspective. Planta Medica. 2025;91:802-813. doi: 10.1055/a-2665-2211
[2] Herath HMUL, Piao MJ, Kang KA, Fernando PDSM, Hyun JW. (2024). Rosmarinic acid inhibits ultraviolet B-mediated oxidative damage via the AKT/ERK-NRF2-GSH pathway in vitro and in vivo. Biomolecules & Therapeutics. 2024;32(1):130-141. doi: 10.4062/biomolther.2023.192
[3] de Macedo LM, Santos ÉMD, Militão L, et al. (2020). Rosemary (Rosmarinus officinalis L., syn Salvia rosmarinus Spenn.) and its topical applications: a review. Plants. 2020;9(5):651. doi: 10.3390/plants9050651
[4] Rashedinia M, Lari P, Abnous K, Shafiei SA. (2023). Neuroprotective effects of carnosic acid: insight into its mechanisms of action. Molecular Neurobiology. 2023;60(4):2011-2027. doi: 10.1007/s12035-022-03175-y
[5] European Commission. (2009). Regulation (EC) No 1223/2009 of the European Parliament and of the Council on Cosmetic Products. Official Journal of the European Union. L 342:59–209. doi: 10.3000/17252555.L_2009.342.eng
